---
document_datetime: 2026-01-26 16:22:41
document_pages: 4
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/recarbrio-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: recarbrio-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 2.4128842
conversion_datetime: 2026-02-01 20:35:37.130906
docling_version:
  docling-serve: 1.11.0
  docling-jobkit: 1.9.1
  docling: 2.71.0
  docling-core: 2.62.0
  docling-ibm-models: 3.11.0
  docling-parse: 4.7.3
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Recarbrio

Procedural steps taken and scientific information after the authorisation*

*Due to the Agency`s update of its procedure management systems, an additional document, reflecting the historical lifecycle may be available in the 'Assessment history' section. For the complete product lifecycle procedures, you may need to also refer to EPAR - Procedural steps taken and scientific information after authorisation (archive) .

| Application number   | Scope                                | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|--------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| Variation type IB /  | B.II.b.3 Change in the manufacturing | 12/01/2026                          | N/A                                         |                                  |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| EMA/VR/0000316318                     | process of the finished product, including an intermediate used in the manufacture of the finished product - B.II.b.3.z Change in the holding time of an intermediate - Accepted                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |            |            |             |                                                                                    |
|---------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-------------|------------------------------------------------------------------------------------|
| Variation type II / EMA/VR/0000265089 | C.I.6 Change(s) to therapeutic indication(s) - C.I.6.a Addition of a new therapeutic indication or modification of an approved one - Accepted Extension of indication to extend the approved adult indications for RECARBRIO to include treatment of paediatric population from birth to <18 years of age, based on final results from two paediatric studies (MK- 7655A-021 and MK-7655A-020); phase 2/3 study MK-7655A-021 addressed safety, tolerability, efficacy and PK, and phase 1b study MK-7655A-020 addressed PK, safety, and tolerability of MK-7655A in paediatric subjects from birth to less than 18 years of age with confirmed or suspected gram- negative infections. As a consequence, sections 4.1, 4.2, 4.4, 4.8, 5.1, 5.2, and 6.6 of the SmPC are updated. The Package Leaflet is updated in accordance. Version 2.1 of the RMP has also been agreed. In addition, the Marketing authorisation holder (MAH) took the opportunity to update the list of local representatives in the Package | 11/12/2025 | 19/01/2026 | SmPC and PL | Please refer to Scientific Discussion 'Recarbrio EMEA/H/C/004808 - VR/0000265089'. |

<div style=\"page-break-after: always\"></div>

|                                       | corrections. The variation leads to amendments to annexes I and IIIB, and to the Risk Management Plan (RMP).                                                                                                                                                                                                                                                                                                                                                                                                              |            |     |                   |
|---------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|-------------------|
| Variation type IB /                   | B.I.b.2 Change in test procedure for active substance or starting material/reagent/intermediate used in the manufacturing process of the active substance - B.I.b.2.e Other changes to a test procedure (including replacement or addition) for the active substance or a starting material/intermediate - Accepted                                                                                                                                                                                                       | 20/11/2025 | N/A | EMA/VR/0000310252 |
| Variation type IA / EMA/VR/0000302295 | A. ADMINISTRATIVE CHANGES - A.4 Change in the name and/or address of: a manufacturer (including where relevant quality control testing sites); or an ASMF holder; or a supplier of the active substance, starting material, reagent or intermediate used in the manufacture of the active substance (where specified in the technical dossier) where no Ph. Eur. Certificate of Suitability is part of the approved dossier; or a manufacturer of a novel excipient (where specified in the technical dossier) - Accepted | 30/09/2025 | N/A |                   |
| Variation type IB /                   | B.I ACTIVE SUBSTANCE - B.I.z Other variation - Accepted                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | 15/09/2025 | N/A | EMA/VR/0000292280 |

<div style=\"page-break-after: always\"></div>

| Variation type IB / EMA/VR/0000267050   | This was an application for a group of variations. B.II.b.5 Change to in-process tests or limits applied during the manufacture of the finished product - B.II.b.5.a Tightening of in- process limits - Accepted B.II. FINISHED PRODUCT - B.II.z Other variation - Accepted   | 28/05/2025   | N/A   |
|-----------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|-------|